Over the latest trailing 12-month period, total return cagr is -31.85%. The comparable SPY value is +16.94%. Year-to-date total return is +8.56%. Total return includes price appreciation and reinvested dividends.
Over the past 12 months, Total Return CAGR is -31.85%. Total return includes dividends reinvested. The total return CAGR includes both price appreciation and dividends reinvested. This gives a more complete picture of the company's investment performance.
Advanced Biomed Inc. Common Stock (ADVB)
Total Return growth vs the same calendar quarter one year earlier, last 4 comparable quarters.
Quarter-end value of $100 invested at the start of the available history, with dividends reinvested; the newest quarter may be quarter-to-date. Q4 2026 (2026-10-05): $8.68.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:10:27.986Z. Historical observations retain their original dates. Historical series through 2026-05-15.
Unrounded diluted TTM EPS / FMP quote price × 100 Quote observation: 2026-10-06T19:10:27.986Z. Historical observations retain their original dates. Historical series through 2026-05-15.
| Year | Total return for the year |
|---|---|
| 2026 (YTD) | +8.56% |
| Period | Period End | QoQ Return | YoY Return |
|---|---|---|---|
| Q4 2026 (QTD) | 2026-10-05 | +1.8% | +8.6% |
| Q3 2026 | 2026-09-30 | +34.0% | -30.5% |
| Q2 2026 | 2026-06-30 | +2.0% | -66.8% |
| Q1 2026 | 2026-03-31 | -21.9% | -94.2% |
| Q4 2025 | 2025-12-31 | -34.8% | N/A |
| Q3 2025 | 2025-09-30 | -36.0% | N/A |
| Q2 2025 | 2025-06-30 | -82.1% | N/A |
| Q1 2025 | 2025-03-31 |
| N/A |
| N/A |
Calendar returns: QoQ compares the prior calendar quarter; YoY compares the same calendar quarter a year earlier. The newest quarter is in progress (quarter-to-date).
